De Novo MS/MS Sequencing of Native Human Antibodies

peer-reviewed · Journal of Proteome Research · 2017

peer-reviewed · Journal of Proteome Research · 2017. Adrian Guthals et al. One direct route for the discovery of therapeutic human monoclonal antibodies (mAbs) involves the isolation…
Date 2017-01-06
Type peer-reviewed
Venue Journal of Proteome Research
Publisher American Chemical Society (ACS)
Contribution downstream-application
DOI 10.1021/acs.jproteome.6b00608
Citations (OpenAlex) 68
Venue 2-year citedness 3.48

Abstract

One direct route for the discovery of therapeutic human monoclonal antibodies (mAbs) involves the isolation of peripheral B cells from survivors/sero-positive individuals after exposure to an infectious reagent or disease etiology, followed by single-cell sequencing or hybridoma generation. Peripheral B cells, however, are not always easy to obtain and represent only a small percentage of the total B-cell population across all bodily tissues. Although it has been demonstrated that tandem mass spectrometry (MS/MS) techniques can interrogate the full polyclonal antibody (pAb) response to an antigen in vivo, all current approaches identify MS/MS spectra against databases derived from genetic sequencing of B cells from the same patient. In this proof-of-concept study, we demonstrate the feasibility of a novel MS/MS antibody discovery approach in which only serum antibodies are required without the need for sequencing of genetic material. Peripheral pAbs from a cytomegalovirus-exposed individual were purified by glycoprotein B antigen affinity and de novo sequenced from MS/MS data. Purely MS-derived mAbs were then manufactured in mammalian cells to validate potency via antigen-binding ELISA. Interestingly, we found that these mAbs accounted for 1 to 2% of total donor IgG but were not detected in parallel sequencing of memory B cells from the same patient.

Authors

  1. Adrian Guthals · Mapp Biopharmaceutical, Inc., University of California San Diego
  2. Yutian Gan · Genentech, Inc.
  3. Laura Murray · Genentech, Inc.
  4. Yongmei Chen · Genentech, Inc.
  5. Jeremy Stinson · Genentech, Inc.
  6. Gerald Nakamura · Genentech, Inc.
  7. Jennie R. Lill · Genentech, Inc.
  8. Wendy Sandoval · Genentech, Inc.
  9. Nuno Bandeira · University of California San Diego

Methods and tools

Cites (5)

Cited by (10)

Seen in the charts

Back to the full map

Back to top